L. Curtiss

发表

MyD88 Deficiency Attenuates Angiotensin II-Induced Abdominal Aortic Aneurysm Formation Independent of Signaling Through Toll-Like Receptors 2 and 4

K. Moore, A. Daugherty, P. Tobias, 2011, Arteriosclerosis, thrombosis, and vascular biology.

Atherosclerosis in Mice Is Not Affected by a Reduction in Tissue Factor Expression

N. Mackman, J. Erlich, Yue-chun Shen, 2005, Arteriosclerosis, thrombosis, and vascular biology.

The NH2-terminal Region of Apolipoprotein B Is Sufficient for Lipoprotein Association with Glycosaminoglycans*

L. Paka, G. S. Shelness, S. Pillarisetti, 1998, The Journal of Biological Chemistry.

Increased Production of Apolipoprotein B-containing Lipoproteins in the Absence of Hyperlipidemia in Transgenic Mice Expressing Cholesterol 7α-Hydroxylase*

Roger A. Davis, J. Taylor, L. Castellani, 2001, The Journal of Biological Chemistry.

A synthetic peptide mimic of plasma apolipoprotein E that binds the LDL receptor.

C. Dyer, L. Curtiss, C. A. Dyer, 1991, The Journal of biological chemistry.

An apolipoprotein E synthetic peptide targets to lipoproteins in plasma and mediates both cellular lipoprotein interactions in vitro and acute clearance of cholesterol-rich lipoproteins in vivo.

L. Curtiss, I. Nikoulin, Igor Nikoulin, 1998, The Journal of clinical investigation.

Regulated Expression of the Apolipoprotein E/C-I/C-IV/C-II Gene Cluster in Murine and Human Macrophages

D. Mangelsdorf, P. Edwards, S. Joseph, 2002, The Journal of Biological Chemistry.

The conformation of apolipoprotein A-I in high-density lipoproteins is influenced by core lipid composition and particle size: a surface plasmon resonance study.

K. Rye, L. Curtiss, L K Curtiss, 2000, Biochemistry.

Apolipoprotein A-I structural organization in high density lipoproteins isolated from human plasma

L. Curtiss, A. Kontush, W. Davidson, 2010, Nature Structural &Molecular Biology.

The impact of glycation on apolipoprotein A-I structure and its ability to activate lecithin:cholesterol acyltransferase

P. Barter, A. Jenkins, K. Rye, 2007, Diabetologia.

What Is So Special About Apolipoprotein AI in Reverse Cholesterol Transport?

K. Rye, L. Curtiss, David T. Valenta, 2006, Arteriosclerosis, thrombosis, and vascular biology.

Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein.

J L Witztum, S. Ylä-Herttuala, J. Witztum, 1990, Arteriosclerosis.

Overexpression of Interleukin-10 by Activated T Lymphocytes Inhibits Atherosclerosis in LDL Receptor–Deficient Mice by Altering Lymphocyte and Macrophage Phenotypes

M. Fishbein, J. Berliner, L. Curtiss, 2002, Circulation research.

Monoclonal autoantibodies specific for oxidized phospholipids or oxidized phospholipid-protein adducts inhibit macrophage uptake of oxidized low-density lipoproteins.

E. Dennis, J. Berliner, N. Leitinger, 1999, The Journal of clinical investigation.

Antiphospholipid antibodies are directed against epitopes of oxidized phospholipids. Recognition of cardiolipin by monoclonal antibodies to epitopes of oxidized low density lipoprotein.

R. Terkeltaub, P. Reaven, J. Witztum, 1996, The Journal of clinical investigation.

Cloning of monoclonal autoantibodies to epitopes of oxidized lipoproteins from apolipoprotein E-deficient mice. Demonstration of epitopes of oxidized low density lipoprotein in human plasma.

J. Witztum, U. Steinbrecher, L. Curtiss, 1996, The Journal of clinical investigation.

Abundant expression of apoprotein E by macrophages in human and rabbit atherosclerotic lesions.

V. Ord, J. Witztum, C. Dyer, 1993, Arteriosclerosis and thrombosis : a journal of vascular biology.

Immunogenicity of homologous low density lipoprotein after methylation, ethylation, acetylation, or carbamylation: generation of antibodies specific for derivatized lysine.

J. Witztum, U. Steinbrecher, L. Curtiss, 1984, Journal of lipid research.

Conservation of the Low Density Lipoprotein Receptor‐Binding Domain of Apoprotein B

S. Young, J. Witztum, L. Curtiss, 1986, Arteriosclerosis.

Parallel expression of the MB19 genetic polymorphism in apoprotein B-100 and apoprotein B-48. Evidence that both apoproteins are products of the same gene.

S. Young, S. Bertics, J. Witztum, 1986, The Journal of biological chemistry.

Apolipoprotein E is a biologically active constituent of the normal immunoregulatory lipoprotein, LDL-In.

L. Curtiss, M. Pepe, 1986, Journal of immunology.

Participation of innate and acquired immunity in atherosclerosis

L. Curtiss, W. Boisvert, N. K. Schiller, 2000, Immunologic research.

Oxidized LDL induces monocytic cell expression of interleukin-8, a chemokine with T-lymphocyte chemotactic activity.

R. Terkeltaub, K. Brand, L. Curtiss, 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

Evaluation of a monoclonal antibody-based enzyme-linked immunosorbent assay as a candidate reference method for the measurement of apolipoprotein B-100.

L. Curtiss, J. Albers, M. S. Lodge, 1989, Journal of lipid research.

Natural antibodies with the T15 idiotype may act in atherosclerosis, apoptotic clearance, and protective immunity.

G. Silverman, L. Curtiss, P. Shaw, 2000, The Journal of clinical investigation.

The LPS2 mutation in TRIF is atheroprotective in hyperlipidemic low density lipoprotein receptor knockout mice

G. Barish, P. Tobias, L. Curtiss, 2013, Innate immunity.

Effect of gamma-irradiation and bone marrow transplantation on atherosclerosis in LDL receptor-deficient mice.

L. Curtiss, W. Boisvert, N. K. Schiller, 2001, Arteriosclerosis, thrombosis, and vascular biology.

Interaction of NADPH oxidase 1 with Toll-like receptor 2 induces migration of smooth muscle cells.

Sunah Kim, C. Yabe-Nishimura, J. Seong, 2013, Cardiovascular research.

Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro.

T. Edgington, L. Curtiss, G. Levy, 1981, The Journal of clinical investigation.

Dietary fish oil-induced decrease in low density lipoprotein binding to fibroblasts is mediated by apolipoprotein E.

Y. Marcel, J. Parks, L. Curtiss, 1994, Journal of lipid research.

Overexpression of human ApoAI transgene provides long-term atheroprotection in LDL receptor-deficient mice.

L. Curtiss, David T. Valenta, Joshua J Bulgrien, 2006, Atherosclerosis.

Single Repeat Deletion in ApoA-I Blocks Cholesterol Esterification and Results in Rapid Catabolism of Δ6 and Wild-type ApoA-I in Transgenic Mice*

L. Curtiss, Michael J. Thomas, M. Sorci-Thomas, 2000, The Journal of Biological Chemistry.

ApoA1 reduces free cholesterol accumulation in atherosclerotic lesions of ApoE-deficient mice transplanted with ApoE-expressing macrophages.

L. Curtiss, W. Boisvert, A. Black, 1999, Arteriosclerosis, thrombosis, and vascular biology.

Quantitation of plasma apolipoprotein A-I using two monoclonal antibodies in an enzyme-linked immunosorbent assay.

L. Curtiss, R. Smith, D. M. Hogle, 1988, Journal of lipid research.

Arteriosclerosis, Thrombosis, and Vascular Biology.

P. Libby, S. Daniels, B. Franklin, 2017, Arteriosclerosis, thrombosis, and vascular biology.

An apolipoprotein E synthetic peptide selectively modulates the transcription of the gene for rat ovarian theca and interstitial cell P450 17alpha-hydroxylase, C17-20 lyase.

C. Dyer, L. Curtiss, R. L. Wade, 1998, Journal of lipid research.

Percutaneous Coronary Intervention Results in Acute Increases in Oxidized Phospholipids and Lipoprotein(a): Short-Term and Long-Term Immunologic Responses to Oxidized Low-Density Lipoprotein

B. Strauss, J. Witztum, A. Segev, 2004, Circulation.

Subdomain Chimeras of Hepatic Lipase and Lipoprotein Lipase

J. Sparrow, L. Curtiss, J. Hill, 1998, The Journal of Biological Chemistry.

Interaction between ApoB and Hepatic Lipase Mediates the Uptake of ApoB-containing Lipoproteins*

Sungshin Y. Choi, I. Goldberg, L. Curtiss, 1998, The Journal of Biological Chemistry.

In vivo efficacy of HDL-like nanolipid particles containing multivalent peptide mimetics of apolipoprotein A-I[S]

M. Ghadiri, L. Curtiss, L. Leman, 2014, Journal of Lipid Research.

Disruption of tissue-specific fucosyltransferase VII, an enzyme necessary for selectin ligand synthesis, suppresses atherosclerosis in mice.

L. Curtiss, W. Boisvert, J. Lowe, 2009, The American journal of pathology.

Treatment of severe hypercholesterolemia in apolipoprotein E-deficient mice by bone marrow transplantation.

L. Curtiss, W. Boisvert, J. Spangenberg, 1995, The Journal of clinical investigation.

Interaction of lipoprotein (a) with the extracellular matrix

L. Curtiss, A. Scanu, J. Hoover-Plow, 1998 .

A PPAR gamma-LXR-ABCA1 pathway in macrophages is involved in cholesterol efflux and atherogenesis.

R. Evans, P. Edwards, A. Chawla, 2001, Molecular cell.

Oxidized LDL enhances lipopolysaccharide-induced tissue factor expression in human adherent monocytes.

R. Terkeltaub, N. Mackman, K. Brand, 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

A single copy of apolipoprotein B-48 is present on the human chylomicron remnant.

V. Schumaker, I. Kroes, C. Pullinger, 1997, Journal of lipid research.

Immunochemical heterogeneity of human plasma high density lipoproteins. Identification with apolipoprotein A-I- and A-II-specific monoclonal antibodies.

T. Edgington, L. Curtiss, 1985, The Journal of biological chemistry.

[19] Immunochemical isolation and identification of glucosylated apolipoproteins

J. Witztum, L. Curtiss, M. Pepe, 1986 .

Translocation of apolipoprotein B across the endoplasmic reticulum is blocked in abetalipoproteinemia.

R. Sokol, L. Curtiss, R. Davis, 1996, Journal of lipid research.

A linkage between the hemostatic and immune systems embodied in the fibrinolytic release of lymphocyte suppressive peptides.

T. Edgington, L. Curtiss, E. Plow, 1985, Journal of immunology.

Interferon-gamma inhibits macrophage apolipoprotein E production by posttranslational mechanisms.

N. Mackman, K. Brand, L. Curtiss, 1993, The Journal of clinical investigation.

Heterogeneous lipoprotein (a) size isoforms differ by their interaction with the low density lipoprotein receptor and the low density lipoprotein receptor‐related protein/α2‐macroglobulin receptor

W. März, H. Scharnagl, W. Schneider, 1993, FEBS letters.

Interaction of Lp(a) with Plasminogen Binding Sites on Cells

L. Curtiss, A. Scanu, J. Hoover-Plow, 1995, Thrombosis and Haemostasis.

Characterization of an abnormal species of apolipoprotein B, apolipoprotein B-37, associated with familial hypobetalipoproteinemia.

S. Young, S. Bertics, J. Witztum, 1987, The Journal of clinical investigation.

TwoNewMonoclonal Antibody-Based Enzyme-Linked Assaysof Apolipoprotein B

S. Young, L. Curtiss, Joseph L Wltztum, 1986 .

A PPARγ-LXR-ABCA1 Pathway in Macrophages Is Involved in Cholesterol Efflux and Atherogenesis

R. Evans, P. Edwards, A. Chawla, 2001 .

Lipoprotein-Associated Phospholipase A2 and Cardiovascular Risk: State of the Evidence and Future Directions

L. Curtiss, David T. Valenta, 2005 .

Phospholipid transfer protein is present in human atherosclerotic lesions and is expressed by macrophages and foam cells Published, JLR Papers in Press, May 1, 2003. DOI 10.1194/jlr.M200281-JLR200

M. Jauhiainen, C. Ehnholm, D. Stupack, 2003, Journal of Lipid Research.

Lipoprotein lipase increases lipoprotein binding to the artery wall and increases endothelial layer permeability by formation of lipolysis products.

J. Rutledge, I. Goldberg, L. Curtiss, 1997, Circulation research.

Differential expression of oxidation-specific epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesions

R. Virmani, F. Otsuka, F. Kolodgie, 2012, Journal of Lipid Research.

Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events

W. Kiosses, P. Tobias, L. Curtiss, 2008, The Journal of experimental medicine.

Effect of &ggr;-Irradiation and Bone Marrow Transplantation on Atherosclerosis in LDL Receptor-Deficient Mice

L. Curtiss, W. Boisvert, N. K. Schiller, 2001 .

Anti-apoprotein B monoclonal antibodies detect human low density lipoprotein polymorphism.

V. Schumaker, L. Curtiss, R. Sparkes, 1984, The Journal of biological chemistry.

Dissociation of LPL and LDL: effects of lipoproteins and anti-apoB antibodies.

I. Goldberg, L. Curtiss, S. Choi, 1997, Journal of lipid research.

Lipoproteins accumulate in immune deposits and are modified by lipid peroxidation in passive Heymann nephritis.

J. Witztum, D. Kerjaschki, S. Spitzauer, 1996, The American journal of pathology.

Isolation of allele-specific, receptor-binding-defective low density lipoproteins from familial defective apolipoprotein B-100 subjects.

R. Krauss, S. Young, L. Curtiss, 1994, Journal of lipid research.

Plasma Apolipoproteins AI, AII, B, CI, and E Are Glucosylated in Hyperglycemic Diabetic Subjects

J. Witztum, L. Curtiss, 1985, Diabetes.

Modulation of peripheral blood mononuclear cell cyclic adenosine monophosphate levels by human very low density lipoprotein

F. Chisari, L. Curtiss, 1981 .

Pathogenic antibodies inhibit the binding of apolipoproteins to megalin/gp330 in passive Heymann nephritis.

J. Witztum, D. Kerjaschki, M. Farquhar, 1997, The Journal of clinical investigation.

Platelet-enhanced apolipoprotein E production by human macrophages: a possible role in atherosclerosis.

C. Dyer, L. Curtiss, Y. Takagi, 1988, Journal of lipid research.

New mechanism for foam cell generation in atherosclerotic lesions.

L. Curtiss, E. Plow, A. Black, 1987, The Journal of clinical investigation.

Identification of a lymphocyte surface receptor for low density lipoprotein inhibitor, an immunoregulatory species of normal human serum low density lipoprotein.

T. Edgington, L. Curtiss, 1978, The Journal of clinical investigation.

A RECEPTOR FOR NORMAL HUMAN SERUM LOW DENSITY LIPOPROTEINS ON PERIPHERAL BLOOD LYMPHOCYTES

T. Edgington, L. Curtiss, 1977 .

of a Lymphocyte Surface Receptor for Low Density Lipoprotein Inhibitor, an Immunoregulatory Species of Normal Human Serum Low

T. Edgington, L. Curtiss, 1977 .

Immunochemical heterogeneity of human plasma apolipoprotein B. I. Apolipoprotein B binding of mouse hybridoma antibodies.

T. Edgington, L. Curtiss, 1982, The Journal of biological chemistry.

Lipoproteins inhibit the secretion of tissue plasminogen activator from human endothelial cells.

L. Curtiss, A. Scanu, E. Plow, 1994, Arteriosclerosis and thrombosis : a journal of vascular biology.

High-level lipoprotein [a] expression in transgenic mice: evidence for oxidized phospholipids in lipoprotein [a] but not in low density lipoproteins.

S. Young, R. E. Pitas, J. Witztum, 2005, Journal of lipid research.

The Hydrophobic Face Orientation of Apolipoprotein A-I Amphipathic Helix Domain 143–164 Regulates Lecithin:Cholesterol Acyltransferase Activation*

J. Parks, L. Curtiss, Michael J. Thomas, 1998, The Journal of Biological Chemistry.

Nonenzymatic Glycation Impairs the Antiinflammatory Properties of Apolipoprotein A-I

P. Barter, A. Jenkins, G. Dusting, 2010, Arteriosclerosis, thrombosis, and vascular biology.

Plasma lipoproteins with bioregulatory properties including the capacity to regulate lymphocyte function and the immune response.

T. Edgington, L. Curtiss, 1981, Cancer research.

THE BIOREGULATORY PROPERTIES OF SERUM LOW DENSITY LIPOPROTEIN INHIBITOR (LDL-IN) ON THE GENERATION OF KILLER T CELLS

T. Edgington, L. Curtiss, C. Henney, 1977 .

Inflammation in Atherosclerosis: Lesion Formation in LDL Receptor–Deficient Mice With Perforin and Lystbeige Mutations

L. Curtiss, W. Boisvert, N. K. Schiller, 2002, Arteriosclerosis, thrombosis, and vascular biology.

Differential sensitivity of lymphocyte subpopulations to suppression by low density lipoprotein inhibitor, an immunoregulatory human serum low density lipoprotein.

T. Edgington, L. Curtiss, 1979, The Journal of clinical investigation.

Effect of LDL-In, a normal immunoregulatory human serum low density lipoprotein, on the interaction of macrophages with lymphocytes proliferating in response to mitogen and allogeneic stimulation.

T. Edgington, L. Curtiss, 1977, Journal of immunology.

Identification of apolipoprotein B100 polymorphisms that affect low-density lipoprotein metabolism: description of a new approach involving monoclonal antibodies and dynamic light scattering.

V. Schumaker, C. Pullinger, J. Kane, 1995, Biochemistry.

Detection of two apolipoprotein B species (apoBc and apoBg) by a monoclonal antibody.

S. Young, J. Witztum, C. Ehnholm, 1987, Atherosclerosis.

Apolipoprotein B allotypes MB19(1) and MB19(2) in subjects with coronary artery disease and hypercholesterolemia.

S. Young, S. Bertics, J. Witztum, 1987, Arteriosclerosis.

Monoclonal antibody detects Ag polymorphism of apolipoprotein B

S. Young, J. Witztum, C. Ehnholm, 1986, FEBS letters.

Monoclonal antibody MB19 detects genetic polymorphism in human apolipoprotein B.

S. Young, S. Bertics, J. Witztum, 1985, Proceedings of the National Academy of Sciences of the United States of America.

Activated Platelets Induce Cholesteryl Ester Accumulation in Monocyte-Derived Macrophages and THP-1 Cells

L. Curtiss, 1990 .

Feasibility of an immunoassay for mevalonolactone.

D. Clark, L. Curtiss, S. Erickson, 1997, Bioorganic & medicinal chemistry.

Genetic analysis of a kindred with familial hypobetalipoproteinemia. Evidence for two separate gene defects: one associated with an abnormal apolipoprotein B species, apolipoprotein B-37; and a second associated with low plasma concentrations of apolipoprotein B-100.

S. Young, S. Bertics, J. Witztum, 1987, The Journal of clinical investigation.

Facilitated replacement of Kupffer cells expressing a paraoxonase-1 transgene is essential for ameliorating atherosclerosis in mice.

Roger A. Davis, Andrew C. Li, C. Glass, 2005, Proceedings of the National Academy of Sciences of the United States of America.

Monocytes can be induced by lipopolysaccharide-triggered T lymphocytes to express functional factor VII/VIIa protease activity

B. Tsao, T. Edgington, L. Curtiss, 1984, The Journal of experimental medicine.

ApoE in atherosclerosis : a protein with multiple hats.

L. Curtiss, 2000, Arteriosclerosis, Thrombosis and Vascular Biology.

Influence of the immunoregulatory serum lipoprotein LDL-In on the in vivo proliferation and differentiation of antigen-binding and antibody-secreting lymphocytes during a primary immune response.

D. Deheer, T. Edgington, L. Curtiss, 1980, Cellular immunology.

The influence of antigen on a model for analysis of multiple coordinate events associated with the primary immune response.

D. Deheer, T. Edgington, L. Curtiss, 1979, Immunopharmacology.

Participation of macrophages in atherosclerotic lesion morphology in LDLr−/− mices⃞s⃞ The online version of this article (available at http://www.jlr.org) contains an additional two figures. Published, JLR Papers in Press, June 1, 2004. DOI 10.1194/jlr.M400036-JLR200

L. Curtiss, N. K. Schiller, D. J. Bonnet, 2004, Journal of Lipid Research.

Deletion of amino acids Glu146-->Arg160 in human apolipoprotein A-I (ApoA-ISeattle) alters lecithin:cholesterol acyltransferase activity and recruitment of cell phospholipid.

E. Rubin, L. Curtiss, T. Forte, 1998, Biochemistry.

Interaction of plasma lipoproteins with human platelets.

L. Curtiss, E. Plow, 1984, Blood.

Two new monoclonal antibody-based enzyme-linked assays of apolipoprotein B.

S. Young, J. Witztum, L. Curtiss, 1986, Clinical chemistry.

Atherosclerosis induced by endogenous and exogenous toll-like receptor (TLR)1 or TLR6 agonists[S]

P. Tobias, L. Curtiss, D. J. Bonnet, 2012, Journal of Lipid Research.

Apolipoprotein (apo) E inhibits the capacity of monosodium urate crystals to stimulate neutrophils. Characterization of intraarticular apo E and demonstration of apo E binding to urate crystals in vivo.

R. Terkeltaub, C. Dyer, L. Curtiss, 1991, The Journal of clinical investigation.

Lipoproteins containing apoprotein B are a major regulator of neutrophil responses to monosodium urate crystals.

R. Terkeltaub, L. Curtiss, M. Ginsberg, 1984, The Journal of clinical investigation.

Physiologic concentrations of normal human plasma lipoproteins inhibit the immortalization of peripheral B lymphocytes by the Epstein-Barr virus.

F. Chisari, F. Jensen, L. Curtiss, 1981, The Journal of clinical investigation.

directed against different domains of complement, C1, by monoclonal antibodies Activation of the first component of human

L. Curtiss, Martín, N. Schumaker, 2001 .

HDL particle size is a critical determinant of ABCA1-mediated macrophage cellular cholesterol export.

K. Rye, L. Curtiss, L. Kritharides, 2015, Circulation research.

Plasma lipoprotein induction and suppression of the generation of cellular procoagulant activity in vitro: two procoagulant activities are produced by peripheral blood mononuclear cells.

T. Edgington, L. Curtiss, G. Levy, 1981, The Journal of clinical investigation.

THP-1 cells form foam cells in response to coculture with lipoproteins but not platelets.

C. Dyer, L. Curtiss, C. Banka, 1991, Journal of lipid research.

Regulatory roles of T mu and T gamma cells in the collaborative cellular initiation of the extrinsic coagulation pathway by bacterial lipopolysaccharide.

T. Edgington, L. Curtiss, G. Levy, 1985, The Journal of clinical investigation.

Expression of the Lyst(beige) mutation is atheroprotective in chow-fed apolipoprotein E-deficient mice.

Yuan Yuan, L. Curtiss, R. J. Petrovan, 2008, Journal of lipid research.

MyD 88 Deficiency Attenuates Angiotensin II-Induced Abdominal Aortic Aneurysm Formation Independent of Signaling Through Toll-Like Receptors 2 and 4

K. Moore, A. Daugherty, P. Tobias, 2011 .

Localization of an apolipoprotein A-I epitope critical for activation of lecithin-cholesterol acyltransferase.

L. Curtiss, R. Smith, C. Banka, 1991, The Journal of biological chemistry.

Effect of long chain polyunsaturated fatty acids in the sn-2 position of phosphatidylcholine on the interaction with recombinant high density lipoprotein apolipoprotein A-I.

A. Gebre, J. Parks, L. Curtiss, 1998, Journal of lipid research.

Localization of two epitopes of apolipoprotein A-I that are exposed on human high density lipoproteins using monoclonal antibodies and synthetic peptides.

L. Curtiss, R. Smith, 1988, The Journal of biological chemistry.

Protection against atherosclerosis by estrogen is independent of plasma cholesterol levels in LDL receptor-deficient mice.

L. Curtiss, C. Banka, V. Walker, 1999, Journal of lipid research.

13C NMR evidence that substitution of glutamine for arginine 3500 in familial defective apolipoprotein B-100 disrupts the conformation of the receptor-binding domain.

L. Curtiss, T. Innerarity, M. Phillips, 1991, The Journal of biological chemistry.

Cord blood plasma lipoproteins inhibit mitogen-stimulated lymphocyte proliferation.

L. Curtiss, P. Davis, T. Forte, 1984, Journal of immunology.

Effect of g-Irradiation and Bone Marrow Transplantation on Atherosclerosis in LDL Receptor–Deficient Mice

L. Curtiss, W. Boisvert, N. K. Schiller, 2001 .

Immunoregulatory plasma low density lipoprotein: the biologic activity and receptor-binding specificity is independent of neutral lipids.

T. Edgington, L. Curtiss, 1981, Journal of immunology.

Altered epitope expression of human interstitial fluid apolipoprotein A-I reduces its ability to activate lecithin cholesterol acyl transferase.

C. Mann, L. Curtiss, P. Roheim, 1992, The Journal of clinical investigation.

The biologic activity of the immunoregulatory lipoprotein, LDL-In is independent of its free fatty acid content.

T. Edgington, L. Curtiss, 1981, Journal of immunology.

Regulatory serum lipoproteins: regulation of lymphocyte stimulation by a species of low density lipoprotein.

T. Edgington, L. Curtiss, 1976, Journal of immunology.

Lipoprotein B37, a naturally occurring lipoprotein containing the amino-terminal portion of apolipoprotein B100, does not bind to the apolipoprotein B,E (low density lipoprotein) receptor.

S. Young, J. Witztum, L. Curtiss, 1987, The Journal of biological chemistry.

Localization of an apolipoprotein A-I epitope critical for lipoprotein-mediated cholesterol efflux from monocytic cells.

L. Curtiss, C. Banka, A. Black, 1994, The Journal of biological chemistry.

Apolipoprotein E and atherosclerosis.

L. Curtiss, W. Boisvert, 2000, Current opinion in lipidology.

Thematic review series: The Immune System and Atherogenesis. Paying the price for pathogen protection: toll receptors in atherogenesis Published, JLR Papers in Press, January 16, 2005. DOI 10.1194/jlr.R400015-JLR200

P. Tobias, L. Curtiss, Linda K Curtiss, 2005, Journal of Lipid Research.

Low density lipoprotein inhibits the physical interaction of phlogistic crystals and inflammatory cells.

R. Terkeltaub, L. Curtiss, M. Ginsberg, 1986, Arthritis and rheumatism.

In vivo suppression of the primary immune response by a species of low density serum lipoprotein.

D. Deheer, T. Edgington, L. Curtiss, 1977, Journal of immunology.

Role of leukocyte-specific LDL receptors on plasma lipoprotein cholesterol and atherosclerosis in mice.

L. Curtiss, W. Boisvert, J. Spangenberg, 1997, Arteriosclerosis, thrombosis, and vascular biology.

Modulation of atherosclerosis in mice by Toll-like receptor 2.

P. Tobias, L. Curtiss, A. Mullick, 2005, The Journal of clinical investigation.

Chemokines and atherosclerosis.

R. Terkeltaub, L. Curtiss, W. Boisvert, 1998, Current opinion in lipidology.

Immunoelectron microscopy of low density lipoproteins yields a ribbon and bow model for the conformation of apolipoprotein B on the lipoprotein surface.

V. Schumaker, J. Fruchart, L. Curtiss, 1995, Journal of lipid research.

Definition of a nonlinear conformational epitope for the apolipoprotein B-100-specific monoclonal antibody, MB47.

R. Koduri, S. Young, L. Curtiss, 1994, Journal of lipid research.

A leukocyte homologue of the IL-8 receptor CXCR-2 mediates the accumulation of macrophages in atherosclerotic lesions of LDL receptor-deficient mice.

R. Terkeltaub, L. Curtiss, W. Boisvert, 1998, The Journal of clinical investigation.

Structural determinants for the interaction of lipopolysaccharide binding protein with purified high density lipoproteins: role of apolipoprotein A-I.

P. Tobias, L. Curtiss, T. Massamiri, 1997, Journal of lipid research.

Application of Monoclonal Antibodies to Issues of Plasma Lipoprotein Structure and Function

L. Curtiss, 1985 .

Immunochemical heterogeneity of human plasma apolipoprotein B. II. Expression of apolipoprotein B epitopes on native lipoproteins.

B. Tsao, T. Edgington, L. Curtiss, 1982, The Journal of biological chemistry.

The relative immunodominance of haptenic determinants on a complex hapten phage conjugate.

L. Curtiss, R. G. Krueger, 1975, Immunochemistry.

Adiposity, dyslipidemia, and insulin resistance in mice with targeted deletion of phospholipid scramblase 3 (PLSCR3).

A. Hevener, J. Olefsky, P. Sims, 2004, Proceedings of the National Academy of Sciences of the United States of America.

PPARδ regulates multiple proinflammatory pathways to suppress atherosclerosis

R. Evans, G. Barish, M. Downes, 2008, Proceedings of the National Academy of Sciences.

Up-regulated expression of the CXCR2 ligand KC/GRO-alpha in atherosclerotic lesions plays a central role in macrophage accumulation and lesion progression.

R. Terkeltaub, S. Lira, M. Fuentes, 2006, The American journal of pathology.

Differences in the characteristics of inhibition of lymphocyte stimulation by 25-hydroxycholesterol and by the immunoregulatory serum lipoprotein LDL-In.

T. Edgington, L. Curtiss, 1980, Journal of Immunology.

Effects of chronic mental stress and atherogenic diet on the immune inflammatory environment in mouse aorta

B. Conti, L. Curtiss, H. Bradlow, 2011, Brain, Behavior, and Immunity.

IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis.

D. Broide, Marina Miller, J. Witztum, 2004, The Journal of clinical investigation.

Serum amyloid A (SAA): influence on HDL-mediated cellular cholesterol efflux.

L. Curtiss, M. Kindy, F. D. de Beer, 1995, Journal of lipid research.

Localization of Coliphage MS2 A-Protein

L. Curtiss, R. G. Krueger, 1974, Journal of virology.

Expression of human apolipoprotein B90 in transgenic mice. Demonstration that apolipoprotein B90 lacks the structural requirements to form lipoprotein.

H. Hobbs, S. Young, M. Linton, 1994, The Journal of biological chemistry.

Toll-like receptors in atherosclerosis.

P. Tobias, L. Curtiss, Peter S. Tobias, 2007, Biochemical Society transactions.

Leukocyte CD11b expression is not essential for the development of atherosclerosis in mice.

C. Ballantyne, L. Curtiss, W. Boisvert, 2000, Journal of lipid research.

DNA Vaccination Against VEGF Receptor 2 Reduces Atherosclerosis in LDL Receptor–Deficient Mice

L. Curtiss, R. Reisfeld, Charles D. Kaplan, 2007, Arteriosclerosis, thrombosis, and vascular biology.

Monocyte tissue factor-dependent activation of coagulation in hypercholesterolemic mice and monkeys is inhibited by simvastatin.

D. Johns, D. Kirchhofer, J. Luyendyk, 2012, The Journal of clinical investigation.

Arteriosclerosis, Thrombosis, and Vascular Biology.

L. Curtiss, Linda Curtiss, 2016, Arteriosclerosis, thrombosis, and vascular biology.

Selection and characterization of monoclonal antibodies for measuring plasma levels of apolipoproteins A-I and B

L. Curtiss, S. Marcovina, J. Albers, 1990 .

High-density lipoprotein enhancement of anticoagulant activities of plasma protein S and activated protein C.

José A Fernández, J. Griffin, L. Curtiss, 1999, The Journal of clinical investigation.

Comparison of the Effects of Apo(a) Kringle IV-10 and Plasminogen Kringles on the Interactions of Lipoprotein(a) with Regulatory Molecules

P. Lograsso, L. Curtiss, E. Madison, 1999, Thrombosis and Haemostasis.

Emerging role of Toll-like receptors in atherosclerosis Published, JLR Papers in Press, November 1, 2008.

P. Tobias, L. Curtiss, Linda K Curtiss, 2009, Journal of Lipid Research.

Elimination of macrophage-specific apolipoprotein E reduces diet-induced atherosclerosis in C57BL/6J male mice.

L. Curtiss, W. Boisvert, 1999, Journal of lipid research.

Influence of macrophage-derived apolipoprotein E on plasma lipoprotein distribution of apolipoprotein A-I in apolipoprotein E-deficient mice.

L. Curtiss, J. Spangenberg, 1997, Biochimica et biophysica acta.

Structural features of synthetic peptides of apolipoprotein E that bind the LDL receptor.

D. Cistola, G. Parry, L. Curtiss, 1995, Journal of lipid research.

Alteration in Apolipoprotein A-I 22-Mer Repeat Order Results in a Decrease in Lecithin:Cholesterol Acyltransferase Reactivity*

J. Parks, L. Curtiss, Michael J. Thomas, 1997, The Journal of Biological Chemistry.

Toll-like receptors and atherosclerosis

P. Tobias, L. Curtiss, A. Mullick, 2006, Immunologic research.

Bone marrow-derived HL mitigates bone marrow-derived CETP-mediated decreases in HDL in mice globally deficient in HL and the LDLr

L. Curtiss, N. Hime, D. J. Bonnet, 2014, Journal of Lipid Research.

A novel method for generating region-specific monoclonal antibodies to modified proteins. Application to the identification of human glucosylated low density lipoproteins.

J. Witztum, L. Curtiss, 1983, The Journal of clinical investigation.

Ag(c): Recognition by a Monoclonal Antibody

V. Schumaker, L. Curtiss, R. Butler, 1986, Arteriosclerosis.

Evidence that endothelial lipase remodels high density lipoproteins without mediating the dissociation of apolipoprotein A-I Published, JLR Papers in Press, February 1, 2005. DOI 10.1194/jlr.M400212-JLR200

D. Rader, K. Rye, L. Curtiss, 2005, Journal of Lipid Research.

Lipoprotein Lipase Association with Lipoproteins Involves Protein-Protein Interaction with Apolipoprotein B (*)

Sungshin Y. Choi, A. Attie, I. Goldberg, 1995, The Journal of Biological Chemistry.

Cellular differences in lipoprotein lipase-mediated uptake of low density lipoproteins.

I. Goldberg, L. Curtiss, R. Deckelbaum, 1994, The Journal of biological chemistry.

An amino-terminal fragment of apolipoprotein B binds to lipoprotein lipase and may facilitate its binding to endothelial cells.

I. Goldberg, L. Curtiss, S. Choi, 1994, The Journal of biological chemistry.

Radiolabeled MDA2, an oxidation-specific, monoclonal antibody, identifies native atherosclerotic lesions in vivo

J. Witztum, L. Curtiss, S. Tsimikas, 1999, Journal of nuclear cardiology : official publication of the American Society of Nuclear Cardiology.

Mapping apolipoprotein B on the low density lipoprotein surface by immunoelectron microscopy.

Y. Marcel, V. Schumaker, L. Curtiss, 1991, The Journal of biological chemistry.

High Density Lipoprotein-Specific Monoclonal Antibodies

L. Curtiss, 1985 .

A Minimally Lipidated Form of Cell-derived Apolipoprotein E Exhibits Isoform-specific Stimulation of Neurite Outgrowth in the Absence of Exogenous Lipids or Lipoproteins*

R. Demattos, L. Curtiss, David L. Williams, 1998, The Journal of Biological Chemistry.

Activation of C1 by monoclonal antibodies directed against C1q.

V. Schumaker, L. Curtiss, E. Kilchherr, 1985, Biochemical and Biophysical Research Communications - BBRC.

The Mechanism of the Remodeling of High Density Lipoproteins by Phospholipid Transfer Protein*

M. Jauhiainen, C. Ehnholm, K. Rye, 2001, The Journal of Biological Chemistry.

Selection of monoclonal antibodies for linear epitopes of an apolipoprotein yields antibodies with comparable affinity for lipid-free and lipid-associated apolipoprotein.

L. Curtiss, C. Banka, 1996, Journal of lipid research.

Atheroprotective Potential of Macrophage-Derived Phospholipid Transfer Protein in Low-Density Lipoprotein Receptor–Deficient Mice Is Overcome by Apolipoprotein AI Overexpression

L. Lagrost, L. Curtiss, David T. Valenta, 2006, Arteriosclerosis, thrombosis, and vascular biology.

The use of monoclonal antibodies to detect genetic polymorphism: application to apolipoprotein B.

V. Schumaker, L. Curtiss, R. Sparkes, 1985, Progress in clinical and biological research.

Is two out of three enough for ABCG1?

L. Curtiss, Linda K Curtiss, 2006, Arteriosclerosis, thrombosis, and vascular biology.

Leukocyte Transglutaminase 2 Expression Limits Atherosclerotic Lesion Size

R. Terkeltaub, O. Quehenberger, L. Curtiss, 2005, Arteriosclerosis, thrombosis, and vascular biology.

Reduced cholesterol and triglycerides in mice with a mutation in Mia2, a liver protein that localizes to ER exit sites[S]

N. Gekakis, L. Curtiss, Jeffrey L. Pitman, 2011, Journal of Lipid Research.

Mimicry of high-density lipoprotein: functional peptide-lipid nanoparticles based on multivalent peptide constructs.

M. Ghadiri, T. Imura, L. Curtiss, 2013, Journal of the American Chemical Society.

Reversing atherosclerosis?

L. Curtiss, 2009, The New England journal of medicine.

Macrophage PLTP is atheroprotective in LDLr-deficient mice with systemic PLTP deficiency Published, JLR Papers in Press, October 10, 2007.

L. Curtiss, David T. Valenta, Joshua J Bulgrien, 2008, Journal of Lipid Research.

Stoichiometric binding of apolipoprotein B-specific monoclonal antibodies to low density lipoproteins.

B. Tsao, L. Curtiss, O. Wiklund, 1985, The Journal of biological chemistry.

Apolipoprotein A-II Inhibits High Density Lipoprotein Remodeling and Lipid-poor Apolipoprotein A-I Formation*

P. Barter, K. Rye, L. Curtiss, 2003, Journal of Biological Chemistry.

Apoprotein E-rich high density lipoproteins inhibit ovarian androgen synthesis.

L. Curtiss, C. A. Dyer, 1988, The Journal of biological chemistry.

TLR2 in murine atherosclerosis

P. Tobias, L. Curtiss, 2008, Seminars in Immunopathology.

Identification and properties of glycated monoclonal IgA that affect the fructosamine assay.

I. Sakurabayashi, L. Curtiss, F. Terasawa, 2003, Clinical chemistry.

Erratum: Differential expression of oxidation-specifi c epitopes and apolipoprotein(a) in progressing and ruptured human coronary and carotid atherosclerotic lesions (J. Lipid Res. (2012) 53 (2773-2790)

R. Virmani, F. Otsuka, F. Kolodgie, 2014 .

Only multimers of a synthetic peptide of human apolipoprotein E are biologically active.

L. Curtiss, R. Smith, C. A. Dyer, 1991, The Journal of biological chemistry.

A method for localizing the early products of nonenzymatic glycosylation in fixed tissue.

J. Olerud, A. Gown, G. Odland, 1989, Journal of Investigative Dermatology.

Studying low-density lipoprotein-monoclonal antibody complexes using dynamic laser light scattering and analytical ultracentrifugation.

V. Schumaker, L. Curtiss, M. Phillips, 1999, Biochemistry.

Effect of Total SMS Activity on LDL Catabolism in Mice

P. Libby, S. Daniels, B. Franklin, 2023 .

Influence of triglyceride enrichment on the remodelling of high density lipoproteins by PLTP

M. Jauhiainen, C. Ehnholm, K. Rye, 2000 .

High-level lipoprotein [a] expression in transgenic mice: Published, JLR Papers in Press, January 16, 2005. DOI 10.1194/jlr.M400467-JLR200evidence for oxidized phospholipids in lipoprotein [a] but not in low density lipoproteins

S. Young, J. Witztum, R. Lawn, 2005, Journal of Lipid Research.

Generation of region‐specific antibodies to modified proteins

J. Witztum, U. Steinbrecher, L. Curtiss, 1987 .

Differential sensitivity of lymphocyte subpopulations to suppression by low density lipoprotein inhibitor, an immunoregulatory human serum low density lipoprotein.

T. Edgington, L. Curtiss, 1979, The Journal of clinical investigation.

Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein.

S. Ylä-Herttuala, L. Curtiss, S. Parthasarathy, 1990, Arteriosclerosis.

Evidence that phospholipids play a key role in pre-beta apoA-I formation and high-density lipoprotein remodeling.

P. Barter, R. Stocker, K. Rye, 2002, Biochemistry.

Increased endothelial expression of Toll-like receptor 2 at sites of disturbed blood flow exacerbates early atherogenic events

W. Kiosses, P. Tobias, L. Curtiss, 2008, The Journal of experimental medicine.

Abstract 42: Monocyte Tissue Factor-Dependent Activation of Coagulation in Hypercholesterolemic Mice and Monkeys Is Inhibited by Simvastatin

D. Johns, D. Kirchhofer, J. Luyendyk, 2012, Arteriosclerosis, Thrombosis, and Vascular Biology.

Monocytes can be induced by lipo poly saccharide stimulated t cells to express factor vii activity

B. Tsao, T. Edgington, L. Curtiss, 1983 .